Business Wire

ImmunityBio and NantKwest Begin Dosing Participants in Global Trials for Novel COVID-19 Vaccine; Subcutaneous Route in South Africa, Oral and Sublingual in the U.S. | Business Wire

These trials will determine which route combination provides the strongest immune response and long-term immunity, as well as the vaccine candidate’s effectiveness against the growing number of ...
Medscape

Which Immunoglobulin Route Best Prevents Infections?

In patients with inborn errors of immunity who are prone to viral infections, immunoglobulin replacement therapy (IRT) administered via the conventional subcutaneous route showed lower viral infection ...
Monthly Prescribing Reference

Boruzu, a Ready-to-Use Bortezomib Formulation, Gets FDA Approval

No dilution is required for the subcutaneous route of administration. The Food and Drug Administration (FDA) has approved Boruzu ™, a ready-to-use formulation of bortezomib for subcutaneous ...
Nasdaq

ImmunityBio and NantKwest Begin Dosing Participants in Global Trials for Novel COVID-19 Vaccine; Subcutaneous Route in South Africa, Oral and Sublingual in the U.S.

One vaccine, three routes for activating the entire immune system and providing T cell, B cell memory, and mucosal protection The first COVID-19 vaccine trials designed to deliver both S and N ...